While epidermal growth factor receptor (EGFR) plays a pivotal role in the repair process of epithelial cells, it is also involved in the overproduction of mucus and goblet cell hyperplasia (GCH), which occurs in chronic airway diseases such as asthma. Among the EGFR ligands, transforming growth factor (TGF)-is thought to be the most important in the synthesis of mucus. Pro-TGF-is cleaved to give an active form by members of the matrix metalloproteinases (MMP)/a disintegrin and metalloproteinases (ADAM) family. Thus MMP/ADAM inhibitors might prevent GCH by inhibiting transactivation of EGFR. Upon stimulation of differentiating normal human bronchial epithelial (NHBE) cells by IL-13, GCH was induced. The mucin genes MUC5AC, MUC5B, and MUC2 were upregulated whereas the expression of ciliated cell markers was greatly repressed. GM6001, a broad-spectrum inhibitor for MMP/ADAM, inhibited IL-13-induced mucin gene expression and mucus production as measured by periodic acid-Schiff staining. This was accompanied by an inhibition of TGF-release. These results suggest that MMP/ADAMs play a pivotal role in the development of GCH in lung epithelial cells.
The bronchial epithelium consists of the surface epithelium and mucus glands. The surface epithelium is made up of the three principal cell types, basal, goblet, and ciliated cells, of which the latter two form a suprabasal columnar structure and are necessary for mucociliary clearance. The apical surface of columnar cells is exposed to the airway lumen and is covered with a protective mucus layer composed mainly of mucin glycoproteins that are produced by goblet cells. Cilia propel mucus in order to clear trapped debris in the mucus from the airway to the pharynx. Thus the combination of goblet and ciliated cells plays a critical role in the body's defense against inhaled particles and noxious substances. 1) In the healthy lung, ciliated cells predominate in the conducting airways, representing more than 80% of the total epithelial cell population, and are interspersed with goblet cells, but in chronic airway diseases such as asthma, cystic fibrosis, and chronic bronchitis, the number of goblet cells increases. This is termed goblet cell hyperplasia (GCH). [2] [3] [4] [5] It results in accelerated production and/or secretion of mucus, which in turn causes resistance to air flow and abrogates normal mucociliary function. The consequences of these changes include increased sputum production, airway narrowing, exacerbation, and asphyxiation in the case of fatal asthma attacks.
2) Despite the severity of the clinical manifestations, the molecular mechanisms underlining GCH remain poorly understood.
It is well known that type 2 CD4 þ T helper lymphocytes (Th2 cells) play an important role in the pathogenesis of asthma. Among various cytokines produced from Th2 cells, interleukin (IL)-13 is thought to be the most important, based on reports that intratracheal instillation of IL-13 causes bronchial hyperresponsiveness (BHR) and GCH, which can be blocked using a soluble form of IL-13 receptor alpha 2.
6,7)
Recently Kuperman et al. have used genetically modified mice in which the expression of signal transducer and activator of transcription 6, an essential signalling molecule activated by IL-13, is confined to the bronchial epithelium, to show that epithelial cells are required and sufficient for IL-13 to induce BHR and GCH.
8) The importance of IL-13 in GCH is supported by in vitro studies showing that direct stimulation of primary lung epithelial cells by IL-13 causes an increase in the population of goblet cells compared to ciliated cells. 9, 10) Epidermal growth factor receptor (EGFR) is known to be involved in GCH and mucus production. Takeyama et al. showed that intratracheal instillation of transforming growth factor (TGF)-, one of the EGFR y To whom correspondence should be addressed. Present address: Infection, Inflammation and Repair Division, School of Medicine, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, United Kingdom; Fax: +44-23-8079-4264; E-mail: hyoshisu@soton.ac.uk Abbreviations: ADAM, a disintegrin and metalloproteinase; ALI, air-liquid interface; BHR, bronchial hyperresponsiveness; EGFR, epidermal growth factor receptor; GCH, goblet cell hyperplasia; MMP, matrix metalloproteinase; NHBE, normal human bronchial epithelial; TACE, tumor necrosis factor-converting enzyme; TGF-, transforming growth factor-ligands, induced GCH, and that pre-treatment with BIBX1522, a selective kinase inhibitor for EGFR, prevented not only GCH induced by TGF-but also GCH induced by OVA in a murine model of asthma. 11) In addition they used NCI-H292, a human pulmonary mucoepidermoid cell line, to show that stimulation with TGF-upregulates expression of the MUC5AC gene, which encodes one of the major mucin proteins in the lung. 11) Reports from several independent research groups have indicated that expression of EGFR is upregulated in the bronchial epithelium of asthmatics. 12, 13) Recently Booth et al. used in vitro differentiated lung epithelial cells on an air-liquid interface (ALI) culture to show that stimulation with IL-13 induced epithelial cell growth. This was accompanied by release of the soluble form of TGF-into the culture supernatant. Pretreatment with a neutralizing antibody for TGF-, but not one for EGF or heparin-binding (HB)-EGF, prevented this IL-13-induced overgrowth. The same inhibitory effect was seen with AG1478, a selective kinase inhibitor for EGFR. 14) Lordan et al. have recently reported that IL-13-or IL-4-stimulated monolayercultured primary bronchial epithelial cells from asthmatics, but not cells from normal subjects, produced more TGF-than cells without stimulation. 15) These results indicate that in asthma Th2 cytokines released from Th2 cells and/or other cells (e.g., mast cells and basophiles), especially IL-13, may induce release of the soluble form of TGF-from the lung epithelium, which in turn can transactivate EGFR to induce mucin gene expression.
Membrane-bound TGF-is inactive and shed to be an active form by members of the matrix metalloproteinases (MMP)/a disintegrin and metalloproteinases (ADAM) protein family. Shedding of TGF-has been shown to be mediated by tumor necrosis factorconverting enzyme (TACE), 16) which is indispensable for normal lung branching morphogenesis. 17) In addition, there is evidence to suggest that other members of the MMP/ADAM family may also be important in TGFshedding. 18) Thus we hypothesized that inhibition of MMP/ADAM metalloproteinase activity would prevent IL-13-triggered effects on bronchial epithelial cells. Hence in this study we assessed the effects of MMP inhibitors on IL-13-induced GCH in vitro.
Materials and Methods
Materials. GM6001 was purchased from Calbiochem (San Diego, California, U.S.A.), and marimastat was synthesized in our laboratories.
Primary cells on air-liquid interface. Normal human bronchial epithelial cells (NHBE) were purchased from Biowhittaker (Walkersville, Maryland, U.S.A.) and maintained in Bronchial Epithelial Growth Medium (BEGM; Biowhittaker). For ALI cultures, passage 2 or 3 cells were trypsinized and seeded into 6.5 mm, 0.4 m pore size collagen-coated transwell culture inserts (Corning Costar, Acton, Massachusetts, U.S.A.) at 2:0 Â 10 5 cells/well. The cells were grown submerged in BEGM medium for 1-3 days, until 90-100% confluent. The apical medium was then removed to expose the cells to the air-liquid interface, and 300 l of basal ALI medium was added to bottom wells comprising a mixture of an equal volume of Dulbecco's Modified Eagle's Medium (Invitrogen, Carlsbad, California, U.S.A.) and Bronchial Epithelial Basal Medium (BEBM; Biowhittaker) containing 52 g/ml Bovine Pituitary Extract, 5 g/ml insulin, 0.5 ng/ml human epidermal growth factor (EGF), 0.5 g/ml hydrocortisone, 10 g/ml transferrin, 0.5 g/ml epinephrine, 6.5 ng/ml triiodothyronine, 1.5 g/ml bovine serum albumin (Sigma, St. Louis, Missouri, U.S.A.), and 50 nM retinoic acid (Sigma). This basal ALI medium was changed every 1-2 days, and differentiation proceeded in a manner similar to that previously described. 19) GCH was induced by the addition of IL-13 (Sigma) at a concentration 20 ng/ml in the basal ALI medium. This treatment was repeated with every change of ALI medium. Cells were treated with drugs one hour before stimulation with IL-13.
RNA isolation and semi-quantitative RT-PCR analysis. Total RNA was isolated from monolayer-or ALIcultured NHBE cells using RNeasy (Qiagen, Germantown, Maryland, U.S.A.), and treated with RNase-free DNase I (Qiagen) in order to remove possible contamination of chromosomal DNA. cDNAs were synthesized from 1 g of total RNA with SuperScript II Reverse Transcriptase (Invitrogen) according to the manufacturer's instructions. One eightieth of each cDNA solution was used for each PCR reaction. The PCR regimen consisted of a 94 C, 2 min initial denaturation step followed by a cycle reaction at 94 C for 1 min, 60 C for 1 min, and 72 C for 1 min on GeneAmp PCR System 9700 (Perkin Elmer, Wellesley, Massachusetts, U.S.A.). The reaction products were subjected to an agarose gel electrophoresis, stained with SYBR Green I (Takara Shuzo, Shiga, Japan), visualized using LAS-1000plus (Fujifilm, Tokyo, Japan), and the intensities of the amplified fragments were quantified by a software system, Image Gauge Ver. 3.11 (Fujifilm). The appropriate numbers of PCR cycles for the semiquantitative analysis were established from the plotting curve of density of each PCR-amplified product. Four independent experiments were done in order to gain averaged values with standard deviations. The specific primers used are shown in Table 1 .
Assessment of mucus production. NHBE cells on ALI culture were suspended in phosphate buffered saline and attached to a slide glass by centrifugation using cytospin. After fixation by ethanol, the cells were subjected to the periodic acid-Schiff (PAS) staining using Schiff's Periodic Acid Staining Kit (Polysciences, Warrington, Pennsylvania, U.S.A.) according to the manufacture's instructions.
ELISA. Release of TGF-into culture supernatants of the differentiating NHBE cells was measured using an ELISA Kit (Oncogene Research Products, San Diego, California, U.S.A.) according to the manufacture's instructions. The concentration of TGF-in each sample was determined by a duplicate assay, which was repeated in three independent experiments in order to gain averaged values with standard deviations.
Statistical analysis. Analysis of the data was performed by Student's t test when the variances from the comparing two groups were statistically equal (P > 0:05), or the Aspin-Welch test when they were statistically unequal (P < 0:05). Differences were considered significant at P < 0:05.
Results

IL-13 induces GCH in NHBE cells on ALI
To confirm the effect of IL-13 on GCH, we treated differentiating NHBE cells with IL-13 and examined the expression level of the MUC5AC gene, whose product is the major mucin expressed in the lung. 20) Semi-quantitative RT-PCR analysis showed that little or no expression occurred in monolayer-cultured and ALI-treated cells at days 1 and 8, although expression was significantly upregulated by IL-13 at day 8 ( Fig. 1) . After 14 days of ALI culture, expression of MUC5AC was clearly upregulated upon stimulation with IL-13 ( Fig. 1) , which led us to examine the expression of other goblet cell markers. Figure 2 shows that additional mucin genes, MUC5B and MUC2, were also transcriptionally upregu- Total RNA was isolated from monolayer-cultured or ALI-differentiating NHBE cells for semi-quantitative RT-PCR analysis of MUC5AC. PCR cycles were 27 for MUC5AC and 20 for the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (G3PDH). The data obtained by SYBR Green I staining were quantified and the expression level of the MUC5AC mRNA was normalized to that of G3PDH. Results are presented as averaged arbitrary units with standard deviations obtained from three independent experiments. Comparisons were made using Student's t test, *P < 0:05; **P < 0:01. lated by IL-13 at day 14 ( Fig. 2D, E) . In addition, the mRNA of the calcium-activated chloride channel (CLCA1), which has been reported to be expressed in goblet cells, 21) was abundant in IL-13-stimulated cells whereas it was negligible in untreated cells (Fig. 2F) . In contrast, the expression of tektin, foxj1 (hepatocyte nuclear factor-3/forkhead homolog 4), and DNAH9 (dynein, axonemal, heavy polypeptide 9), marker genes for ciliated cells, was dramatically repressed by IL-13 treatment (Fig. 2H-J) . This indicates that, as reported previously, IL-13 modulates the differentiation process of bronchial epithelial cells to deviate cell fate toward goblet cells rather than ciliated cells, 9, 10) mimicking the in vivo situation of GCH. The expression of CCSP, which codes for the Clara cell secretory protein, also known as uteroglobin or CC10, was slightly downregulated, not upregulated, by IL-13 (Fig. 2G) . This might reflect the fact that CCSP is expressed in nongranulated secretory cells (Clara cells) rather than mature goblet cells, 22) and that IL-13 increased the population of granulated (mature) goblet cells and accordingly decreased the ratio of nongranulated secretory cells.
MMP inhibitors prevent GCH
In order to investigate the role MMP/ADAMs play in GCH, we treated the ALI-differentiating NHBE cells with a prototype inhibitor of MMP/ADAMs, GM6001 or marimastat. Pretreatment with GM6001, a broadspectrum inhibitor of MMP/ADAMs, at a concentration of 40 M, clearly abrogated upregulation of three mucin gene expression by IL-13 ( Fig. 2A-E) . Treatment with GM6001 at 4 M, however, did not significantly prevent upregulation of MUC5AC or MUC5B expression ( Fig. 2A, B) . IL-13-induced expression of CLCA1 also diminished upon pretreatment of GM6001 at 40 M (Fig. 2F) . In contrast, treatment with GM6001 did not prevent the IL-13-induced downregulation of ciliated cell specific transcripts (Fig. 2H-J) . Marimastat, a
Fig. 2. Effect of GM6001 (A-K) or Marimastat (L-N) on Expression of Epithelial Genes during Mucocilia Differentiation Modulated by IL-13.
NHBE cells on ALI culture were treated by GM6001 at a concentration of 4 M (3) or 40 M (4), marimastat at 1 M (5) or 10 M (6), or DMSO (1 and 2), followed by the addition of IL-13 (2-6) at a concentration of 20 ng/ml after one h. This treatment was repeated every day for 14 d, and total RNA was isolated from the cells for semi-quantitative RT-PCR analysis using specific primers for MUC5AC (C), MUC5B (D, M), MUC2 (E), CLCA1 (F), CCSP (G), tektin (H), foxj1 (I), DNAH9 (J), and G3PDH (K, N). For quantification, PCR cycles were 27 for MUC5AC and MUC5B and 20 for G3PDH. The data obtained by SYBR Green I staining were quantified and the expression level of MUC5AC or MUC5B was normalized to that of G3PDH (A, B, L). The results are presented as averaged arbitrary units with standard deviations obtained from four independent experiments. Comparisons were made using Student's t test, **P < 0:01; ***P < 0:001, or the Aspin-Welch test, $P < 0:05. NS, not significant. The PCR cycles used for the other genes are as follows: 33 for MUC2, 25 for CCSP, and 35 for CLCA1, tektin, foxj1, and DNAH9.
prototype inhibitor for TACE, also known to have an inhibitory activity toward various MMPs, significantly abrogated expression of MUC5B at 10 M (Fig. 2L, M) .
In order to confirm the effects of the inhibitors on mucin gene expression, we stained NHBE cells 14 d after culture on ALI with PAS. As expected, given the transcriptional upregulation of mucin genes, stimulation by IL-13 for 14 d greatly increased the intensity of PASpositive signals, reflecting the abundant expression of mucins and induction of GCH. Pretreatment of the cells with GM6001 at 40 M one hour before IL-13 stimulation, which was repeated for 14 d, completely abrogated the overproduction of mucus (Fig. 3) .
The values of transcellular electrical resistance of ALI-cultured NHBE cells at days 8 and 14 were not different between drug-treated and non-treated cells, indicating that chronic treatment with GM6001 (40 M) or marimastat (10 M) does not affect the integrity of the polarized NHBE cells (data not shown).
Inhibition of GCH is accompanied by reduced TGFshedding
The importance of the EGFR in the induction of mucin synthesis and the remarkable inhibition of GCH by MMP/ADAM inhibitors prompted us to hypothesize that shedding of some EGFR ligands might have been abrogated by the inhibitors. Hence we assessed the concentration of TGF-in the supernatants, which had been exposed for 24 h to NHBE cells on ALI at day 10. Figure 4 shows that IL-13 treatment increased the concentration of TGF-(197%, P ¼ 0:0159) as previously reported by Booth et al. 14) Furthermore, pretreatment of the cells with GM6001 at 40 M, the same concentration that caused downregulation of IL-13-induced MUC genes, significantly repressed shedding of TGF-(11.3%, P ¼ 0:0013), while treatment with GM6001 at 4 M did not cause a significant reduction in the amount of TGF-(72.5%, P ¼ 0:1122). NHBE cells on ALI culture at day 14, which had been treated with only DMSO (A), DMSO and IL-13 (B), or GM6001 (40 M) and IL-13 (C), were subjected to cytospin centrifugation followed by PAS staining (red) with hematoxylin and eosin counter staining (blue). Representative results from two independent experiments are shown. Fig. 4 . Effect of GM6001 on TGF-Shedding from Differentiating NHBE Cells. NHBE cells on ALI culture at day 10 were treated by GM6001 at a concentration of 4 M (3) or 40 M (4), or by DMSO (1, 2), followed by the addition of IL-13 (2-4) after one h. After 24-hour stimulation, ALI medium was collected and assayed by ELISA. Comparisons were made using Student's t test, *P < 0:05; **P < 0:01. NS, not significant. The results are presented as averaged values with standard deviations obtained from three independent experiments.
Discussion
Recently, several reports have indicated that primary bronchial or nasal epithelial cells cultivated in differentiating conditions are induced to differentiate into goblet cells more readily than ciliated cells upon stimulation with IL-13. Laoukili et al. used human nasal epithelial cells to show that not only IL-13 but also IL-4 increases the population of goblet cells and decreases that of ciliated cells, with a decrease in ciliary beat frequency. 9) Kondo et al. used primary lung epithelial cells from guinea pig ALI culture to indicate clearly that IL-13 induced GCH with consequent overproduction of the MUC5AC protein. No similar effect was seen with IL-4. 10) On the other hand, Chen et al. reported that both IL-6 and IL-17 stimulate transcription of both MUC5AC and MUC5B in well differentiated NHBE cells, whereas the Th2 cytokines IL-4, IL-9, and IL-13 upregulated neither mucin gene. 23) Furthermore, there are reports that treatment with IL-4 or IL-13 reduces mucin secretion rather than stimulating it in ALI-cultured NHBE cells, although the reduction ratio of mucin secretion is approximately 50% and downregulation of the mRNA of MUC5AC and MUC5B is not so evident. 24, 25) Hence we first assessed whether NHBE cells on ALI culture respond to IL-13 by differentiation into goblet cells. In our model, 14 days after being placed at the ALI, they upregulated not only the MUC5AC gene but also other mucin genes (MUC5B and MUC2) in response to chronic stimulation with IL-13. Cells at days 1 and 8 showed little expression of MUC5AC regardless of the presence or absence of IL-13. This is consistent with previous reports showing that IL-13-induced GCH in vitro takes two to three weeks. 9, 10) Cells might be able to respond to IL-13 only at later differentiation stages, or chronic treatment with IL-13 at earlier differentiation stages might render cells more responsive to IL-13. Overproduction of mucus by IL-13 was confirmed by PAS staining, and CLCA1, whose expression is reported to increase in asthmatics, 26) was also induced by IL-13. A murine ortholog of CLCA1, gob5, has been stated to be implicated not only in GCH but also in BHR. 21) The unchanged or slightly reduced CCSP expression in response to IL-13 observed appears contradictory to previous observations that intratracheal instillation of IL-13 increases expression of both CCSP mRNA and protein in the epithelial cells of pathogen-free rat airways. 27) But CCSP is generally thought to be expressed predominantly in nongranulated secretory cells in normal human lung epithelium 22) and therefore not to be a marker of goblet cells. Furthermore, expression of CCSP is reported to decrease in areas of GCH, 28) which is consistent with our in vitro results. On the other hand, expression of the mRNA for tektin, encoding a structural component of cilia, 29) was diminished completely by the addition of IL-13. A similar expression pattern was observed for other ciliated cell marker genes: foxj1, which codes for a ciliated cellspecific transcription factor, 30) and DNAH9, encoding a component of the dynein arm of cilia. 31) To our knowledge, this is the first report showing that IL-13 modulates the expression profile of the genes in ex vivo differentiating lung epithelial cells.
GM6001 is widely used in both in vitro and in vivo studies as a MMP inhibitor. A recent report by Lemjabbar and Basbaum indicated that lipoteichoic acid (LTA) binds to the platelet-activating factor receptor on lung epithelial cells to activate ADAM10, and that this results in shedding of HB-EGF and transactivation of the EGFR, leading to induction of mucin production. In addition, they found that GM6001 inhibits LTA-induced shedding of HB-EGF at a concentration of 40 M, accompanied by inhibition of mucus production. Given that LTA is a component of the infectious bacterium Staphylococcus aureus, they considered this in vitro model useful for the study of cystic fibrosis. 32) Extrapolating from this model, it is reasonable to hypothesize that in asthma, IL-13 might activate a member(s) of the MMP/ADAM protein family (e.g., TACE) on bronchial epithelial cells, resulting in release of TGF-, transactivation of the EGFR, GCH, and hypersecretion of mucus. The results of this study support this hypothesis, since GM6001 at 40 M inhibited IL-13-induced upregulation of MUC genes and CLCA1 and overproduction of mucus.
In order to test this hypothesis further, we measured levels of TGF-in the supernatant of the differentiating NHBE cells on ALI using ELISA. This indicated that the amount of TGF-increased approximately two-fold upon stimulation by IL-13. This level of increase is not as marked as that found by Booth et al., although they used NHBE cells on day 9 of ALI.
14) The differentiation stages appeared to be similar to those used in this study. This may be due to differences in the cells' origin and/ or the culture conditions, and/or differences in the experimental design. Specifically, they stimulated NHBE cells with IL-13 from both the apical and basal faces of the ALI culture while in this study it was from the basal side, because we did not want to change the usual culture conditions for ALI and it has been reported that TGF-is delivered preferentially to the basolateral surface of the polarized epithelial cells. 33) As expected, GM6001 at 40 M prevented shedding of TGF-from the differentiating NHBE cells. The lack of significant inhibition at 4 M is consistent with the effect of this drug on mucin gene expression. Since the concentration of TGF-in the supernatant of the cells treated with GM6001 (40 M) and IL-13 was only 22.2% compared to that of the cells with only DMSO (P ¼ 0:020), it is clear that this MMP/ADAM inhibitor prevented not only IL-13-induced shedding, but also the basal level of shedding. This reduction in basal TGF-levels was not accompanied by repression of basal expression of the MUC genes, raising the possibility that basal expression of MUC genes is independent of TGF-and/or MMP/ ADAMs. On the other hand, CCSP expression was downregulated in a concentration-dependent manner by GM6001, indicating that basal level expression of CCSP in differentiating NHBE cells depends on MMP/ ADAMs, TGF-, and/or other EGFR ligands.
Although a member(s) of the MMP/ADAM protein family are probably involved in the increase of soluble TGF-in supernatant in response to IL-13, its precise molecular mechanism has not been well defined. Because Booth et al. reported that an increase in soluble TGF-in the supernatant was observed only 1 h after stimulation with IL-13, it is unlikely that a member(s) of the MMP/ADAM protein family affect transcription and/or translation of the TGF-gene. Rather, it is probably activated by an intracellular signaling triggered by IL-13, and hence its extracellular catalytic domain cleaves the membrane-bound pro-TGF-. In this study, however, we did not detect significant shedding of TGFat 1 h after stimulation with IL-13 (data not shown). This might be due to the difference in methods noted above. The possibility that the de novo synthesis of pro-TGF-is affected by IL-13 and/or GM6001 remains to be clarified.
During the preparation of this manuscript, Shao et al. reported that an endogenous knockdown of TACE expression by small interfering RNA blocked phorbol 12-myristate 13-acetate-induced TGF-shedding, EGFR transactivation, and MUC5AC expression in H292 cells. 34) Given that TGF--mediated mucus production has also been reported in H292 cells, 11) it is likely that TACE is also involved in EGFR-mediated expression of mucin genes in primary epithelial cells. Pharmacological inhibition of TACE might be a novel strategy for GCH and mucus hypersecretion.
